Lynx1 Capital Management LP Gh Research PLC Transaction History
Lynx1 Capital Management LP
- $257 Million
- Q4 2024
A detailed history of Lynx1 Capital Management LP transactions in Gh Research PLC stock. As of the latest transaction made, Lynx1 Capital Management LP holds 4,858,994 shares of GHRS stock, worth $69.5 Million. This represents 13.21% of its overall portfolio holdings.
Number of Shares
4,858,994
Previous 4,195,894
15.8%
Holding current value
$69.5 Million
Previous $28.1 Million
21.17%
% of portfolio
13.21%
Previous 10.05%
Shares
7 transactions
Others Institutions Holding GHRS
# of Institutions
36Shares Held
28.5MCall Options Held
13.1KPut Options Held
4.9K-
Bvf Inc San Francisco, CA10.4MShares$149 Million2.72% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$95.7 Million0.76% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$47.6 Million0.38% of portfolio
-
Verition Fund Management LLC Greenwich, CT918KShares$13.1 Million0.03% of portfolio
-
Cormorant Asset Management, LP Boston, MA593KShares$8.49 Million0.33% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $744M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...